EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...

The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, while the index remained in the “Fear” zone on Tuesday.U.S. stocks settled higher on Tuesday, with the Dow Jones index gaining more than 100 points during the session despite escalating geopolitical tensions and trade uncertainties between the world's two largest economies.China responded to President Donald Trump‘s 10% import tariff with targeted countermeasures, including restrictions on key mineral exports to the ...

EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...

NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conference, with a webcast available at Nasdaq’s Investor Relations website: ir.nasdaq.com/events.cfm. Who:Adena Friedman, Chair & CEO, Nasdaq What:2025 UBS Financial Services Conference When:Monday, February 10, 20251:00 PM ET About Nasdaq Nasdaq (Nasdaq: NDAQ) is a global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and in ...

NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for January 2025 on its Investor Relations website. A data sheet showing this information can be found at: http://ir.nasdaq.com/financials/volume-statistics. About Nasdaq Nasdaq (Nasdaq: NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the broader financial system. ...

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Tuesday.The Dow traded up 0.17% to 44,499.60 while the NASDAQ gained 1.19% to 19,621.76. The S&P 500 also rose, gaining, 0.64% to 6,032.76.Check This Out: Jim Cramer: AutoZone Is A ‘Great’ Stock, Recommends Buying This Energy StockLeading and Lagging SectorsEnergy shares surged by 1.9% on Monday.In trading on Monday, consumer staples shares fell by 0.7%.Top HeadlineOn Tuesday, Pfizer Inc. PFE reported ...

WALTHAM, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, effective February 1, 2025, the company granted non-qualified stock options to purchase an aggregate of 83,400 shares of its common stock to four new employees under Xilio Therapeutics’ 2022 Inducement Stock Incentive Plan. The stock options have an exercise pr ...

EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...

Core Insights - The Nasdaq-100 Index® (NDX®) celebrates its 40th anniversary, marking its evolution into a leading benchmark for large-cap growth companies globally [1][5] - The index has delivered a 14.25% compound annualized return since its inception, showcasing the transformative power of its constituent companies [2] - The combined value of all investment products tracking the NDX® ecosystem exceeds $500 billion, with 94 Exchange Traded Products available in over 20 countries [8] Investment Performance - The Nasdaq-100 Index® tracks 100 of the largest non-financial companies listed on the Nasdaq Stock Market, which have a legacy of market disruption and global growth [2] - The median market capitalization of companies in the NDX® has increased from $455 million at inception to $74 billion as of December 31, 2024 [3] Research and Development - Companies within the Nasdaq-100® invest significantly more in research and development, spending between 600-1,200% more compared to broader US large-cap equity indexes [4] - This investment in R&D has correlated with above-average performance and resilience across various market conditions [4] Ecosystem Growth - The NDX® ecosystem has seen substantial growth in investment vehicles, including a 39.5% increase in index options volume from 2023 to 2024 [9] - CME's Nasdaq 100® futures have an average notional value traded daily exceeding $200 billion in 2024, providing additional exposure avenues for investors [9] Industry Impact - The Nasdaq-100 Index® serves as a powerful embodiment of innovation and economic growth, enabling the creation of generational wealth for investors [5] - Nasdaq's commitment to supporting companies at all stages of their journey is reflected in the index's role in shaping the future of markets worldwide [5][9]

EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...